Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19

Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19

Abstract The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and trea...

Full description

Bibliographic Details
Main Authors: Mohamad Y. Khatib, Karimulla S. Shaik, Amna A. Ahmed, Mohammad A. Alwraidat, Ahmed S. Mohamed, Mohamad R. Abou Kamar, Mouhammad Z. Sharaf Eldean, Bashar K. Aldaraiseh, Abdulqadir J. Nashwan
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Clinical Case Reports
Subjects:
COVID‐19
cytomegalovirus colitis
double‐barrel colostomy
lower gastrointestinal bleeding
tocilizumab
Online Access:https://doi.org/10.1002/ccr3.3487

Internet

https://doi.org/10.1002/ccr3.3487

Similar Items